Recent Update on Pretreatment and Analysis Methods of Buprenorphine in Different Matrix

References

• Penno, J.; Young, J.; Ding, J.; Moushi, J.; Chou, J. Sublingual Buprenorphine for Acute Postoperative Cancer Pain: A Retrospective Study. J. Pharm. Pract. Res. 2021, 51, 390–395. DOI: 10.1002/jppr.1748.
   Google Scholar
• Davis, M. P.; Pasternak, G.; Behm, B. Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option. Drugs 2018, 78 (12), 1211–1228. DOI: 10.1007/s40265-018-0953-z.
   PubMed Web of Science ®Google Scholar
  Dalal, S.; Chitneni, A.; Berger, A. A.; Orhurhu, V.; Dar, B.; Kramer, B.; Nguyen, A.; Pruit, J.; Halsted, C.; Kaye, A. D. Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids. Health Psychol. Res. 2021, 9, 27241. DOI: 10.52965/001c.27241.
   PubMedGoogle Scholar
• Tang, Y.; Zhang, Y.; Zhao, J.; Xue, F.; He, H.; Xue, F.; Liu, X.-Y.; Qin, Y. Asymmetric Total Synthesis of Buprenorphine and Dihydroetorphine. Tetrahedron Lett. 2022, 104, 154027. DOI: 10.1016/j.tetlet.2022.154027.
   Google Scholar
• Belivanis, S.; Tzatzarakis, M. N.; Vakonaki, E.; Kovatsi, L.; Mantsi, M.; Alegakis, A.; Kavvalakis, M. P.; Vynias, D.; Tsatsakis, A. M. Buprenorphine and Nor-Buprenorphine Levels in Head Hair Samples from Former Heroin Users under Suboxone(R) Treatment. Drug Test. Anal. 2014, 6, 93–100. DOI: 10.1002/dta.1611.
   PubMed Web of Science ®Google Scholar
• McPhail, B. T.; Emoto, C.; Butler, D.; Fukuda, T.; Akinbi, H.; Vinks, A. A. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches. J. Clin. Pharmacol. 2021, 61, 857–870. DOI: 10.1002/jcph.1811.
   PubMed Web of Science ®Google Scholar
• Davis, M. P.; Fudin, J. Buprenorphine Not a Silver Bullet But an Opioid of Choice for Chronic Pain. J. Opioid Manage. 2021, 17, 11–14. DOI: 10.5055/jom.2021.0619.
   Google Scholar
• Meaden, C. W.; Mozeika, A.; Asri, R.; Santos, C. D. A Review of the Existing Literature on Buprenorphine Pharmacogenomics. Pharmacogenomics J. 2021, 21, 128–139. DOI: 10.1038/s41397-020-00198-1.
   PubMed Web of Science ®Google Scholar
• Chan, K.-W.; Harun, H. Liquid Chromatography Tandem Mass Spectrometric Method Validation for the Quantification of Buprenorphine and Norbuprenorphine in Whole Blood. Aust. J. Forensic Sci. 2017, 49, 186–200. DOI: 10.1080/00450618.2016.1153148.
   Web of Science ®Google Scholar
• Spreen, L. A.; Dittmar, E. N.; Quirk, K. C.; Smith, M. A. Buprenorphine Initiation Strategies for Opioid Use Disorder and Pain Management: A Systematic Review. Pharmacotherapy 2022, 42, 411–427. DOI: 10.1002/phar.2676.
   PubMedGoogle Scholar
• Erosa, S. C.; Haffey, P. R.; Mehta, N.; Gulati, A. Tapentadol, Buprenorphine, and Levorphanol for the Treatment of Neuropathic Pain: A Systematic Review. Curr. Pain Headache Rep. 2021, 25, 18. DOI: 10.1007/s11916-020-00934-z.
   PubMedGoogle Scholar
• Chilcoat, H. D.; Amick, H. R.; Sherwood, M. R.; Dunn, K. E. Buprenorphine in the United States: Motives for Abuse, Misuse, and Diversion. J. Subst. Abuse Treat. 2019, 104, 148–157. DOI: 10.1016/j.jsat.2019.07.005.
   PubMed Web of Science ®Google Scholar
• Hale, M.; Garofoli, M.; Raffa, R. B. Benefit-Risk Analysis of Buprenorphine for Pain Management. J. Pain Res. 2021, 14, 1359–1369. DOI: 10.2147/JPR.S305146.
   PubMed Web of Science ®Google Scholar
• DeWeese, J. P.; Krenz, J. R.; Wakeman, S. E.; Peckham, A. M. Rapid Buprenorphine Microdosing for Opioid Use Disorder in a Hospitalized Patient Receiving Very High Doses of Full Agonist Opioids for Acute Pain Management: Titration, Implementation Barriers, and Strategies to Overcomes. Subst. Abuse 2021, 42 (4), 506–511. DOI: 10.1080/08897077.2021.1915914;
   PubMedGoogle Scholar
  Mariottini, C.; Kriikku, P.; Ojanpera, I. Concomitant Drugs with Buprenorphine User Deaths. Drug Alcohol Depend. 2021, 218, 108345. DOI: 10.1016/j.drugalcdep.2020.108345; Mariottini, C.; Kriikku, P.; Ojanpera, I. Investigation of Buprenorphine-Related Deaths Using Urinary Metabolite Concentrations. Drug Test. Anal. 2022. DOI: 10.1002/dta.3347.
   PubMedGoogle Scholar
• Jamalian, S. M.; Sotodeh, M.; Mohaghegh, F. Comparison of Sublingual Buprenorphine and Intravenous Morphine in Reducing Bone Metastases Associated Pain in Cancer Patients. Eur. J. Transl. Myol. 2019, 29, 8098–8129. DOI: 10.4081/ejtm.2019.8098.
   PubMed Web of Science ®Google Scholar
• Langel, K.; Gunnar, T.; Ariniemi, K.; Rajamaki, O.; Lillsunde, P. A Validated Method for the Detection and Quantitation of 50 Drugs of Abuse and Medicinal Drugs in Oral Fluid by Gas Chromatography-Mass Spectrometry. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2011, 879, 859–870. DOI: 10.1016/j.jchromb.2011.02.027.
   PubMed Web of Science ®Google Scholar
• Strano-Rossi, S.; Bermejo, A. M.; de la Torre, X.; Botre, F. Fast GC-MS Method for the Simultaneous Screening of THC-COOH, Cocaine, Opiates and Analogues Including Buprenorphine and Fentanyl, and Their Metabolites in Urine. Anal. Bioanal. Chem. 2011, 399, 1623–1630. DOI: 10.1007/s00216-010-4471-4.
   PubMed Web of Science ®Google Scholar
• Wang, Y. S.; Lin, D. L.; Yang, S. C.; Wu, M. Y.; Liu, R. H.; Su, L. W.; Cheng, P. S.; Liu, C.; Fuh, M. R. Issues Pertaining to the Analysis of Buprenorphine and Its Metabolites by Gas Chromatography-Mass Spectrometry. J. Chromatogr. A 2010, 1217, 1688–1694. DOI: 10.1016/j.chroma.2010.01.038.
   PubMedGoogle Scholar
• Berg, T.; Jorgenrud, B.; Strand, D. H. Determination of Buprenorphine, Fentanyl and LSD in Whole Blood by UPLC-MS-MS. J. Anal. Toxicol. 2013, 37, 159–165. DOI: 10.1093/jat/bkt005.
   PubMedGoogle Scholar
• Feliu, C.; Konecki, C.; Binet, L.; Vautier, D.; Haudecoeur, C.; Oget, O.; Fouley, A.; Marty, H.; Gozalo, C.; Cazaubon, Y.; et al. Quantification of Methadone, Buprenorphine, Naloxone, Opioids, and Their Derivates in Whole Blood by Liquid Chromatography-High-Resolution Mass Spectrometry: Analysis of Their Involvement in Fatal Forensic Cases. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2020, 1152, 122226. DOI: 10.1016/j.jchromb.2020.122226.
   PubMed Web of Science ®Google Scholar
• Pirro, V.; Fusari, I.; Corcia, D. D.; Gerace, E.; Vivo, E. D.; Salomone, A.; Vincenti, M. Hair Analysis for Long-Term Monitoring of Buprenorphine Intake in Opiate Withdrawal. Ther. Drug Monit. 2014, 36, 796–807.
   PubMedGoogle Scholar
• Sørensen, L. K.; Hasselstrøm, J. B. A High-Throughput Multi-Class Liquid Chromatography Tandem Mass Spectrometry Method for Quantitative Determination of Licit and Illicit Drugs in Whole Blood. Anal. Methods 2013, 5, 3185. DOI: 10.1039/c3ay40443a.
   Google Scholar
• Tikhomirov, M.; Poźniak, B.; Śniegocki, T. High-Performance Liquid Chromatography-Tandem Mass Spectrometry for Buprenorphine Evaluation in Plasma-Application to Pharmacokinetic Studies in Rabbits. Molecules 2021, 26, 437. DOI: 10.3390/molecules26020437.
   PubMedGoogle Scholar
• Wang, Y. Y.; Shen, X. H.; Li, H.; Chen, F. J.; Fu, Y.; Ding, L. A Sensitive, Simple and Rapid HPLC-MS/MS Method for Simultaneous Quantification of Buprenorpine and Its N-Dealkylated Metabolite Norbuprenorphine in Human Plasma. J. Pharm. Anal. 2013, 3, 221–228. DOI: 10.1016/j.jpha.2012.12.002.
   PubMedGoogle Scholar
• Chiang, T.-Y.; Pao, L.-H.; Hsiong, C.-H.; Huang, P.-W.; Lin, K.-W.; Hu, O. Y.-P. Simultaneous Determination of Buprenorphine, Norbuprenorphine and Naloxone in Human Plasma by LC-MS-MS. Chromatographia 2011, 74, 575–583. DOI: 10.1007/s10337-011-2095-2.
   Google Scholar
• Lin, H. R.; Chen, C. L.; Huang, C. L.; Chen, S. T.; Lua, A. C. Simultaneous Determination of Opiates, Methadone, Buprenorphine and Metabolites in Human Urine by Superficially Porous Liquid Chromatography Tandem Mass Spectrometry. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2013, 925, 10–15. DOI: 10.1016/j.jchromb.2013.02.020.
   PubMedGoogle Scholar
• Liu, Y.; Li, X.; Xu, A.; Nasser, A. F.; Heidbreder, C. Simultaneous Determination of Buprenorphine, Norbuprenorphine and Naloxone in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2016, 120, 142–152. DOI: 10.1016/j.jpba.2015.12.008.
   PubMedGoogle Scholar
• Oechsler, S.; Skopp, G. Buprenorphine and Major Metabolites in Blood Specimens Collected for Drug Analysis in Law Enforcement Purposes. Forensic Sci. Int. 2010, 195, 73–77. DOI: 10.1016/j.forsciint.2009.11.015.
   PubMedGoogle Scholar
• Saleh, A.; Stephanson, N. N.; Granelli, I.; Villen, T.; Beck, O. Evaluation of a Direct High-Capacity Target Screening Approach for Urine Drug Testing Using Liquid Chromatography-Time-of-Flight Mass Spectrometry. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2012, 909, 6–13. DOI: 10.1016/j.jchromb.2012.10.006.
   PubMed Web of Science ®Google Scholar
• Farquharson, S.; Dana, K.; Shende, C.; Gladding, Z.; Newcomb, J.; Dascher, J.; Petrakis, I. L.; Arias, A. J. Rapid Identification of Buprenorphine in Patient Saliva. J. Anal. Bioanal. Tech. 2017, 08, 368. DOI: 10.4172/2155-9872.1000368.
   Google Scholar
• Ensafi, A. A.; Khoddami, E.; Rezaei, B. A Combined Liquid Three-Phase Micro-Extraction and Differential Pulse Voltammetric Method for Preconcentration and Detection of Ultra-Trace Amounts of Buprenorphine Using a Modified Pencil Electrode. Talanta 2013, 116, 1113–1120. DOI: 10.1016/j.talanta.2013.08.016.
   PubMedGoogle Scholar
• Kohler, I.; Schappler, J.; Sierro, T.; Rudaz, S. Dispersive Liquid-Liquid Microextraction Combined with Capillary Electrophoresis and Time-of-Flight Mass Spectrometry for Urine Analysis. J. Pharm. Biomed. Anal. 2013, 73, 82–89. DOI: 10.1016/j.jpba.2012.03.036.
   PubMed Web of Science ®Google Scholar
• Hasheminasab, K. S.; Fakhari, A. R. Development and Application of Carbon Nanotubes Assisted Electromembrane Extraction (CNTs/EME) for the Determination of Buprenorphine as a Model of Basic Drugs from Urine Samples. Anal. Chim. Acta 2013, 767, 75–80. DOI: 10.1016/j.aca.2012.12.046.
   PubMedGoogle Scholar
• Fisichella, M.; Odoardi, S.; Strano-Rossi, S. High-Throughput Dispersive Liquid/Liquid Microextraction (DLLME) Method for the Rapid Determination of Drugs of Abuse, Benzodiazepines and Other Psychotropic Medications in Blood Samples by Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) and Application to Forensic Cases. Microchem. J. 2015, 123, 33–41. DOI: 10.1016/j.microc.2015.05.009.
   Web of Science ®Google Scholar
• Sun, W.; Qu, S.; Du, Z. Hollow Fiber Liquid-Phase Microextraction Combined with Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry for the Simultaneous Determination of Naloxone, Buprenorphine and Norbuprenorphine in Human Plasma. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2014, 951–952, 157–163. DOI: 10.1016/j.jchromb.2014.01.029.
   PubMedGoogle Scholar
• Anzillotti, L.; Odoardi, S.; Strano-Rossi, S. Cleaning up Blood Samples Using a Modified "QuEChERS" Procedure for the Determination of Drugs of Abuse and Benzodiazepines by UPLC-MSMS. Forensic Sci. Int. 2014, 243, 99–106. DOI: 10.1016/j.forsciint.2014.05.005.
   PubMedGoogle Scholar
• Alves, M. N.; Piccinotti, A.; Tameni, S.; Polettini, A. Evaluation of Buprenorphine LUCIO Immunoassay versus GC-MS Using Urines from a Workplace Drug Testing Program. J. Anal. Toxicol. 2013, 37, 175–178. DOI: 10.1093/jat/bkt006.
   PubMedGoogle Scholar
• Castro, A. L.; Tarelho, S.; Silvestre, A.; Teixeira, H. M. Simultaneous Analysis of Some Club Drugs in Whole Blood Using Solid Phase Extraction and Gas Chromatography-Mass Spectrometry. J Forensic Legal Med. 2012, 19, 77–82. DOI: 10.1016/j.jflm.2011.12.006.
   PubMedGoogle Scholar
• Chiadmi, F.; Schlatter, J. Buprenorphine and Norbuprenorphine Determination in Mice Plasma and Brain by Gas Chromatography-Mass Spectrometry. Anal. Chem. Insights 2014, 9, 9–16. DOI: 10.4137/ACI.S13515.
   PubMedGoogle Scholar
• Gervais, J. R.; Hobbs, G. A. Use of an Acetyl Derivative to Improve GC-MS Determination of Norbuprenorphine in the Presence of High Concentrations of Buprenorphine in Urine. J. Anal. Toxicol. 2016, 40, 208–212. DOI: 10.1093/jat/bkw001.
   PubMedGoogle Scholar
• Nahar, L. K.; Andrews, R.; Paterson, S. Validated Method for the Quantification of Buprenorphine in Postmortem Blood Using Solid-Phase Extraction and Two-Dimensional Gas Chromatography-Mass Spectrometry. J. Anal. Toxicol. 2015, 39, 519–525. DOI: 10.1093/jat/bkv051.
   PubMedGoogle Scholar
• Papoutsis, I. I.; Nikolaou, P. D.; Athanaselis, S. A.; Pistos, C. M.; Spiliopoulou, C. A.; Maravelias, C. P. Development and Validation of a Highly Sensitive GC/MS Method for the Determination of Buprenorphine and nor-Buprenorphine in Blood. J. Pharm. Biomed. Anal. 2011, 54, 588–591. DOI: 10.1016/j.jpba.2010.09.023.
   PubMedGoogle Scholar
• Schubert, B.; Pitterl, F.; Saxl, B.; Pavlic, M. A Novel Enzyme Immunoassay for the Detection of Buprenorphine, Norbuprenorphine and Their Glucuronides in Urine. J. Anal. Toxicol. 2019, 43, 364–368. DOI: 10.1093/jat/bkz003.
   PubMedGoogle Scholar
• Boogaerts, T.; Quireyns, M.; Covaci, A.; De Loof, H.; van Nuijs, A. L. N. Analytical Method for the Simultaneous Determination of a Broad Range of Opioids in Influent Wastewater: Optimization, Validation and Applicability to Monitor Consumption Patterns. Talanta 2021, 232, 122443. DOI: 10.1016/j.talanta.2021.122443.
   PubMed Web of Science ®Google Scholar
• Bade, R.; Ghetia, M.; Nguyen, L.; Tscharke, B. J.; White, J. M.; Gerber, C. Simultaneous Determination of 24 Opioids, Stimulants and New Psychoactive Substances in Wastewater. MethodsX 2019, 6, 953–960. DOI: 10.1016/j.mex.2019.04.016.
   PubMed Web of Science ®Google Scholar
• Bjork, M. K.; Nielsen, M. K.; Markussen, L. O.; Klinke, H. B.; Linnet, K. Determination of 19 Drugs of Abuse and Metabolites in Whole Blood by High-Performance Liquid Chromatography-Tandem Mass Spectrometry. Anal. Bioanal. Chem. 2010, 396, 2393–2401. DOI: 10.1007/s00216-009-3268-9.
   PubMedGoogle Scholar
• Christoffersen, D. J.; Brasch-Andersen, C.; Thomsen, J. L.; Worm-Leonhard, M.; Damkier, P.; Brosen, K. Quantification of Morphine, Morphine 6-Glucuronide, Buprenorphine, and the Enantiomers of Methadone by Enantioselective Mass Spectrometric Chromatography in Whole Blood. Forensic Sci. Med. Pathol. 2015, 11, 193–201. DOI: 10.1007/s12024-015-9673-9.
   PubMed Web of Science ®Google Scholar
• Concheiro, M.; Jones, H.; Johnson, R. E.; Shakleya, D. M.; Huestis, M. A. Confirmatory Analysis of Buprenorphine, Norbuprenorphine, and Glucuronide Metabolites in Plasma by LCMSMS. Application to Umbilical Cord Plasma from Buprenorphine-Maintained Pregnant Women. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2010, 878, 13–20. DOI: 10.1016/j.jchromb.2009.11.005.
   PubMedGoogle Scholar
• Concheiro, M.; Shakleya, D. M.; Huestis, M. A. Simultaneous Analysis of Buprenorphine, Methadone, Cocaine, Opiates and Nicotine Metabolites in Sweat by Liquid Chromatography Tandem Mass Spectrometry. Anal. Bioanal. Chem. 2011, 400, 69–78. DOI: 10.1007/s00216-010-4392-2.
   PubMedGoogle Scholar
• Dubois, N.; Debrus, B.; Hubert, P.; Charlier, C. Validated Quantitative Simultaneous Determination of Cocaine, Opiates and Amphetamines in Serum by U-Hplc Coupled to Tandem Mass Spectrometry. Acta Clin. Belgica 2010, 65(supl 1), 75–84. DOI: 10.1179/acb.2010.113.
   Web of Science ®Google Scholar
• Eckart, K.; Rohrich, J.; Breitmeier, D.; Ferner, M.; Laufenberg-Feldmann, R.; Urban, R. Development of a New Multi-Analyte Assay for the Simultaneous Detection of Opioids in Serum and Other Body Fluids Using Liquid Chromatography-Tandem Mass Spectrometry. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2015, 1001, 1–8. DOI: 10.1016/j.jchromb.2015.06.028.
   PubMed Web of Science ®Google Scholar
• Guo, Q.; Du, Z. Development of a Rapid and Simultaneous Detection Method for Buprenorphine, Norbuprenorphine and Naloxone in Human Plasma Using Ultra-High Performance Liquid Chromatographytandem Mass Spectrometer with Solid-Phase Extraction. Chin. J. Chem. 2011, 29, 1922–1926. DOI: 10.1002/cjoc.201180334.
   Google Scholar
• Kyle, A. R.; Carmical, J.; Shah, D.; Pryor, J.; Brown, S. UHPLC-MS/MS Quantification of Buprenorphine, Norbuprenorphine, Methadone, and Glucuronide Conjugates in Umbilical Cord Plasma. Biomed. Chromatogr. 2015, 29, 1567–1574. DOI: 10.1002/bmc.3460.
   PubMed Web of Science ®Google Scholar
• Marin, S. J.; McMillin, G. A. Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS. Methods Mol. Biol. 2016, 1383, 69–78. DOI: 10.1007/978-1-4939-3252-8_8.
   PubMedGoogle Scholar
• Mariottini, C.; Gergov, M.; Ojanpera, I. Determination of Buprenorphine, Norbuprenorphine, Naloxone, and Their Glucuronides in Urine by Liquid Chromatography-Tandem Mass Spectrometry. Drug Test. Anal. 2021, 13, 1658–1667. DOI: 10.1002/dta.3104.
   Google Scholar
• Øiestad, E. L.; Johansen, U.; Øiestad, Å. M. L.; Christophersen, A. S. * Drug Screening of Whole Blood by Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry. J. Anal. Toxicol. 2011, 35, 280–293. DOI: 10.1093/anatox/35.5.280.
   PubMed Web of Science ®Google Scholar
• Ramírez Fernández, MdM.; Van Durme, F.; Wille, S. M.; di Fazio, V.; Kummer, N.; Samyn, N. Validation of an Automated Solid-Phase Extraction Method for the Analysis of 23 Opioids, Cocaine, and Metabolites in Urine with Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry. J. Anal. Toxicol. 2014, 38, 280–288. DOI: 10.1093/jat/bku024.
   PubMedGoogle Scholar
• Ransohoff, J. R.; Petrides, A. K.; Piscitello, G. J.; Flood, J. G.; Melanson, S. E. F. Urine is Superior to Oral Fluid for Detecting Buprenorphine Compliance in Patients Undergoing Treatment for Opioid Addiction. Drug Alcohol Depend. 2019, 203, 8–12. DOI: 10.1016/j.drugalcdep.2019.06.015.
   PubMedGoogle Scholar
• Regina, K. J.; Kharasch, E. D. High-Sensitivity Analysis of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, and Norbuprenorphine Glucuronide in Plasma and Urine by Liquid Chromatography-Mass Spectrometry. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2013, 939, 23–31. DOI: 10.1016/j.jchromb.2013.09.004.
   PubMed Web of Science ®Google Scholar
• Ristimaa, J.; Gergov, M.; Pelander, A.; Halmesmaki, E.; Ojanpera, I. Broad-Spectrum Drug Screening of Meconium by Liquid Chromatography with Tandem Mass Spectrometry and Time-of-Flight Mass Spectrometry. Anal. Bioanal. Chem. 2010, 398, 925–935. DOI: 10.1007/s00216-010-3942-y.
   PubMedGoogle Scholar
• Stephenson, J. B. Analysis of Buprenorphine in Whole Blood Using Liquid Chromatography-Tandem Mass Spectrometry. J. Anal. Toxicol. 2013, 37, 495–499. DOI: 10.1093/jat/bkt074.
   PubMedGoogle Scholar
• Swortwood, M. J.; Scheidweiler, K. B.; Barnes, A. J.; Jansson, L. M.; Huestis, M. A. Simultaneous Quantification of Buprenorphine, Naloxone and Phase I and II Metabolites in Plasma and Breastmilk by Liquid Chromatography-Tandem Mass Spectrometry. J. Chromatogr. A 2016, 1446, 70–77. DOI: 10.1016/j.chroma.2016.03.076.
   PubMed Web of Science ®Google Scholar
• Truver, M. T.; Swortwood, M. J. Quantitative Analysis of Novel Synthetic Opioids, Morphine and Buprenorphine in Oral Fluid by LC-MS-MS. J. Anal. Toxicol. 2018, 42, 554–561. DOI: 10.1093/jat/bky053.
   PubMedGoogle Scholar
• Tzatzarakis, M. N.; Vakonaki, E.; Kovatsi, L.; Belivanis, S.; Mantsi, M.; Alegakis, A.; Liesivuori, J.; Tsatsakis, A. M. Determination of Buprenorphine, Norbuprenorphine and Naloxone in Fingernail Clippings and Urine of Patients under Opioid Substitution Therapy. J. Anal. Toxicol. 2015, 39, 313–320. DOI: 10.1093/jat/bkv003.
   PubMedGoogle Scholar
• Verplaetse, R.; Tytgat, J. Development and Validation of a Sensitive UPLC-MS/MS Method for the Analysis of Narcotic Analgesics in Urine and Whole Blood in Forensic Context. Forensic Sci. Int. 2012, 215, 136–145. DOI: 10.1016/j.forsciint.2011.01.047.
   PubMed Web of Science ®Google Scholar
• Viaene, J.; Lanckmans, K.; Dejaegher, B.; Mangelings, D.; Vander Heyden, Y. Comparison of a Triple-Quadrupole and a Quadrupole Time-of-Flight Mass Analyzer to Quantify 16 Opioids in Human Plasma. J. Pharm. Biomed. Anal. 2016, 127, 49–59. DOI: 10.1016/j.jpba.2015.12.055.
   PubMedGoogle Scholar
• Valen, A.; Leere Oiestad, A. M.; Strand, D. H.; Skari, R.; Berg, T. Determination of 21 Drugs in Oral Fluid Using Fully Automated Supported Liquid Extraction and UHPLC-MS/MS. Drug Test. Analysis 2017, 9, 808–823. DOI: 10.1002/dta.2045.
   PubMed Web of Science ®Google Scholar
• Hernandez, A.; Lacroze, V.; Doudka, N.; Becam, J.; Pourriere-Fabiani, C.; Lacarelle, B.; Solas, C.; Fabresse, N. Determination of Prenatal Substance Exposure Using Meconium and Orbitrap Mass Spectrometry. Toxics 2022, 10, 55. DOI: 10.3390/toxics10020055.
   PubMedGoogle Scholar
• Gomar, F.; Afkhami, A.; Madrakian, T. Highly Sensitive Simultaneous Quantification of Buprenorphine and Norbuprenorphine in Human Plasma by Magnetic Solid-Phase Extraction Based on PpPDA/Fe3O4 Nanocomposite and High-Performance Liquid Chromatography. J Iran Chem SOC 2018, 15, 575–585. DOI: 10.1007/s13738-017-1257-z.
   Google Scholar
• Birch, M. A.; Couchman, L.; Pietromartire, S.; Karna, T.; Paton, C.; McAllister, R.; Marsh, A.; Flanagan, R. J. False-Positive Buprenorphine by CEDIA in Patients Prescribed Amisulpride or Sulpiride. J. Anal. Toxicol. 2013, 37, 233–236. DOI: 10.1093/jat/bkt016.
   PubMed Web of Science ®Google Scholar
• Thirukumaran, M.; Singh, V.; Arao, Y.; Fujito, Y.; Nishimura, M.; Ogura, T.; Pawliszyn, J. Solid-Phase Microextraction- Probe Electrospray Ionization Devices for Screening and Quantitating Drugs of Abuse in Small Amounts of Biofluids. Talanta 2021, 231, 122317. DOI: 10.1016/j.talanta.2021.122317.
   PubMedGoogle Scholar
• Somaini, L.; Saracino, M. A.; Marcheselli, C.; Zanchini, S.; Gerra, G.; Raggi, M. A. Combined Liquid Chromatography-Coulometric Detection and Microextraction by Packed Sorbent for the Plasma Analysis of Long Acting Opioids in Heroin Addicted Patients. Anal. Chim. Acta 2011, 702, 280–287. DOI: 10.1016/j.aca.2011.06.032.
   PubMedGoogle Scholar
• Habibi, B.; Rostamkhani, S.; Hamidi, M. Magnetic Molecularly Imprinted Polymer Nanoparticles for Dispersive Micro Solid-Phase Extraction and Determination of Buprenorphine in Human Urine Samples by HPLC-FL. J. Iran Chem. SOC 2018, 15, 1569–1580. DOI: 10.1007/s13738-018-1355-6.
   Google Scholar
• Montesano, C.; Simeoni, M. C.; Curini, R.; Sergi, M.; Lo Sterzo, C.; Compagnone, D. Determination of Illicit Drugs and Metabolites in Oral Fluid by Microextraction on Packed Sorbent Coupled with LC-MS/MS. Anal. Bioanal. Chem. 2015, 407, 3647–3658. DOI: 10.1007/s00216-015-8583-8.
   PubMed Web of Science ®Google Scholar
• Ares, A. M.; Fernandez, P.; Regenjo, M.; Fernandez, A. M.; Carro, A. M.; Lorenzo, R. A. A Fast Bioanalytical Method Based on Microextraction by Packed Sorbent and UPLC-MS/MS for Determining New Psychoactive Substances in Oral Fluid. Talanta 2017, 174, 454–461. DOI: 10.1016/j.talanta.2017.06.022.
   PubMed Web of Science ®Google Scholar
• Ganjavi, F.; Ansari, M.; Kazemipour, M.; Zeidabadinejad, L. Computational Design, Synthesis and Utilization of a Magnetic Molecularly Imprinted Polymer on Graphene Oxide Nanosheets for Highly Selective Extraction and Determination of Buprenorphine in Biological Fluids and Tablets. Anal. Methods 2018, 10, 5214–5226. DOI: 10.1039/C8AY01757C.
   Google Scholar
• Mohammadi, F.; Shabani, A. M. H.; Dadfarnia, S.; Ansari, M.; Asgharinezhad, A. A. Dispersive Solid-Phase Extraction of Buprenorphine from Biological Fluids Using Metal-Organic Frameworks and Its Determination by Ultra-Performance Liquid Chromatography. J. Sep. Sci. 2020, 43, 3045–3052. DOI: 10.1002/jssc.202000221.
   PubMedGoogle Scholar
• Gomez-Rios, G. A.; Liu, C.; Tascon, M.; Reyes-Garces, N.; Arnold, D. W.; Covey, T. R.; Pawliszyn, J. Open Port Probe Sampling Interface for the Direct Coupling of Biocompatible Solid-Phase Microextraction to Atmospheric Pressure Ionization Mass Spectrometry. Anal. Chem. 2017, 89, 3805–3809. DOI: 10.1021/acs.analchem.6b04737.
   PubMed Web of Science ®Google Scholar
• Gholivand, M. B.; Jalalvand, A. R.; Goicoechea, H. C.; Skov, T. Fabrication of an Ultrasensitive Impedimetric Buprenorphine Hydrochloride Biosensor from Computational and Experimental Angles. Talanta 2014, 124, 27–35. DOI: 10.1016/j.talanta.2014.02.017.
   PubMedGoogle Scholar
• Kul, A.; Ozdemir, M.; Ozilhan, S.; Sagirli, O. A Rapid Method for the Determination of Buprenorphine and Norbuprenorphine in Urine by UPLC-MS/MS. Curr. Pharm. Anal. 2021, 17, 926–931. DOI: 10.2174/1573412916999200627010536.
   Google Scholar
• Terrell, A. R.; Adhlakha, V.; Reddy, P. Measurement of Buprenorphine and Norbuprenorphine in Urine. Methods Mol. Biol. 2019, 1872, 51–59. DOI: 10.1007/978-1-4939-8823-5_5.
   PubMedGoogle Scholar
• Phillips, S. J.; Oliveto, A.; Mancino, M. J.; Hendrickson, H. P. Development and Validation of a Rapid Liquid Chromatography/Tandem Mass Spectrometry Method to Quantitate Gabapentin and Buprenorphine in Human Serum. Rapid Commun. Mass Spectrom. 2021, 35, e9104. DOI: 10.1002/rcm.9104.
   PubMedGoogle Scholar
• Coulter, C.; Garnier, M.; Moore, C. Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases. J. Anal. Toxicol. 2022, DOI: 10.1093/jat/bkac031.
   PubMedGoogle Scholar
• Liu, H. C.; Lee, H. T.; Hsu, Y. C.; Huang, M. H.; Liu, R. H.; Chen, T. J.; Lin, D. L. Direct Injection LC-MS-MS Analysis of Opiates, Methamphetamine, Buprenorphine, Methadone and Their Metabolites in Oral Fluid from Substitution Therapy Patients. J. Anal. Toxicol. 2015, 39, 472–480. DOI: 10.1093/jat/bkv041.
   PubMed Web of Science ®Google Scholar
• Massarini, E.; Wästerby, P.; Landström, L.; Lejon, C.; Beck, O.; Andersson, P. O. Methodologies for Assessment of Limit of Detection and Limit of Identification Using Surface-Enhanced Raman Spectroscopy. Sens. Actuators, B 2015, 207, 437–446. DOI: 10.1016/j.snb.2014.09.116.
   Web of Science ®Google Scholar
• Berg, J. A.; Schjott, J.; Fossan, K. O.; Riedel, B. Cross-Reactivity of the CEDIA Buprenorphine Assay in Drugs-of-Abuse Screening: Influence of Dose and Metabolites of Opioids. Subst. Abuse Rehabil 2015, 6, 131–139. DOI: 10.2147/SAR.S88935.
   PubMedGoogle Scholar
• Plattner, S.; Pavlic, M.; Pitterl, F.; Schubert, B. Consumption of the Sugar Substitute Stevia Leads to Cross-Reactivity of CEDIA(R) Buprenorphine II Immunoassay. J. Anal. Toxicol. 2021, 45, 1052–1057. DOI: 10.1093/jat/bkaa167.
   PubMedGoogle Scholar
• Yahyapour, M.; Ranjbar, M.; Mohadesi, A.; Rejaeinegad, M. Determination of Buprenorphine (BUP) with Molecularly Imprinted Polymer Zn/La 3 + Metal Organic Framework on Modified Glassy Carbon Electrode (GCE). Electroanalysis 2021, 34, 1012–1020. DOI: 10.1002/elan.202100266.
   Google Scholar
• Alizadeh, T.; Atashi, F.; Akhoundian, M.; Ganjali, M. R. Highly Selective Extraction and Voltammetric Determination of the Opioid Drug Buprenorphine via a Carbon Paste Electrode Impregnated with Nano-Sized Molecularly Imprinted Polymer. Mikrochim. Acta 2019, 186, 654. DOI: 10.1007/s00604-019-3736-7.
   PubMed Web of Science ®Google Scholar
• Hatefi-Mehrjardi, A.; Boldaji, S. R.; Yaftian, M. R.; Shayani-Jam, H. Anion-Doped Overoxidized Polypyrrole/Multiwalled Carbon Nanotubes Modified Glassy Carbon Electrode as a New Electrochemical Sensing Platform for Buprenorphine Opioid Drug. Iran. J. Anal. Chem. 2021, 8, 56–64. DOI: 10.30473/ijac.2021.59410.1194.
   Google Scholar
• Behpour, M.; Valipour, A.; Keshavarz, M. Determination of Buprenorphine by Differential Pulse Voltammetry on Carbon Paste Electrode Using SDS as an Enhancement Factor. Mater. Sci. Eng. C Mater. Biol. Appl. 2014, 42, 500–505. DOI: 10.1016/j.msec.2014.05.067.
   PubMed Web of Science ®Google Scholar
• Fakhari, A. R.; Sahragard, A.; Ahmar, H. Development of an Electrochemical Sensor Based on Reduced Graphene Oxide Modified Screen-Printed Carbon Electrode for the Determination of Buprenorphine. Electroanalysis 2014, 26, 2474–2483. DOI: 10.1002/elan.201400196.
   Web of Science ®Google Scholar
• Jahanbakhshi, M. In Situ Synthesis of Rhodium nanoparticles - Mesoporous Carbon Hybrid via a Novel and Facile Nanocasting Method for Simultaneous Determination of Morphine and Buprenorphine. Mater. Sci. Eng. C Mater. Biol. Appl. 2019, 97, 479–485. DOI: 10.1016/j.msec.2018.12.019.
   PubMed Web of Science ®Google Scholar
• Greene, D. N.; Lehman, C. M.; McMillin, G. A. Evaluation of the Integrated E-Z Split Key® Cup II for Rapid Detection ofTwelve Drug Classes in Urine. J. Anal. Toxicol. 2011, 35, 46–53. DOI: 10.1093/anatox/35.1.46.
   PubMed Web of Science ®Google Scholar
• Li, S. J.; Wang, D.; Zhang, J.; Zheng, J.; Chen, W. X. Development of Test Strips for Rapid Buprenorphine Detection in Vitro. Clin. Biochem. 2013, 46, 1093–1098. DOI: 10.1016/j.clinbiochem.2013.05.001.
   PubMedGoogle Scholar
• Melanson, S. E.; Snyder, M. L.; Jarolim, P.; Flood, J. G. A New Highly Specific Buprenorphine Immunoassay for Monitoring Buprenorphine Compliance and Abuse. J. Anal. Toxicol. 2012, 36, 201–206. DOI: 10.1093/jat/bks003.
   PubMed Web of Science ®Google Scholar
• Vindenes, V.; Yttredal, B.; Øiestad, E. L.; Waal, H.; Bernard, J. P.; Mørland, J. G.; Christophersen, A. S. Oral Fluid is aViable Alternative for Monitoring Drug Abuse: Detection of Drugs in Oral Fluid by Liquid Chromatography–TandemMass Spectrometry and Comparison to the Results from Urine Samples from Patients Treated with Methadone or Buprenorphine. J. Anal. Toxicol. 2011, 35, 32–39. DOI: 10.1093/anatox/35.1.32.
   PubMed Web of Science ®Google Scholar
• Bassotti, E.; Merone, G. M.; D'Urso, A.; Savini, F.; Locatelli, M.; Tartaglia, A.; Dossetto, P.; D'Ovidio, C.; de Grazia, U. A New LC-MS/MS Confirmation Method for the Determination of 17 Drugs of Abuse in Oral Fluid and Its Application to Real Samples. Forensic Sci. Int. 2020, 312, 110330. DOI: 10.1016/j.forsciint.2020.110330.
   PubMed Web of Science ®Google Scholar
• Belsey, S. L.; Couchman, L.; Flanagan, R. J. Buprenorphine Detection in Urine Using Liquid Chromatography-High-Resolution Mass Spectrometry: Comparison with Cloned Enzyme Donor Immunoassay (ThermoFisher) and Homogeneous Enzyme Immunoassay (Immunalysis). J. Anal. Toxicol. 2014, 38, 438–443. DOI: 10.1093/jat/bku060.
   PubMedGoogle Scholar
• Danso, D.; Langman, L. J.; Jannetto, P. J. Targeted Opioid Screening Assay for Pain Management Using High-Resolution Mass Spectrometry. Methods Mol. Biol. 2019, 1872, 41–50. DOI: 10.1007/978-1-4939-8823-5_4.
   PubMedGoogle Scholar
• Rochani, A.; Nguyen, V.; Becker, R.; Kraft, W.; Kaushal, G. Stability-Indicating LC-MS Method for Determination of Stability of Extemporaneously Compounded Buprenorphine Oral Syringes for Neonatal Abstinence Syndrome. J. Pediatr. Pharmacol. Ther. 2021, 26, 395–404. DOI: 10.5863/1551-6776-26.4.395.
   PubMedGoogle Scholar
• Wang, J.; Yang, Z.; Lechago, J. Rapid and Simultaneous Determination of Multiple Classes of Abused Drugs and Metabolites in Human Urine by a Robust LC-MS/MS Method - Application to Urine Drug Testing in Pain Clinics. Biomed. Chromatogr. 2013, 27, 1463–1480. DOI: 10.1002/bmc.2945.
   PubMedGoogle Scholar
• Guo, A. Y.; Ma, J. D.; Best, B. M.; Atayee, R. S. Urine Specimen Detection of Concurrent Nonprescribed Medicinal and Illicit Drug Use in Patients Prescribed Buprenorphine. J. Anal. Toxicol. 2013, 37, 636–641. DOI: 10.1093/jat/bkt082.
   PubMed Web of Science ®Google Scholar
• Bakke, E.; Hoiseth, G.; Arnestad, M.; Gjerde, H. Detection of Drugs in Simultaneously Collected Samples of Oral Fluid and Blood. J. Anal. Toxicol. 2019, 43, 228–232. DOI: 10.1093/jat/bky079.
   PubMed Web of Science ®Google Scholar
• Agostini, M.; Renzoni, C.; Pierini, E.; Piergiovanni, M.; Termopoli, V.; Famiglini, G.; Palma, P.; Cappiello, A. Rapid, Hydrolysis-Free, Dilute-and-Shoot Method for the Determination of Buprenorphine, Norbuprenorphine and Their Glucuronides in Urine Samples Using UHPLC-MS/MS. J. Pharm. Biomed. Anal. 2019, 166, 236–243. DOI: 10.1016/j.jpba.2019.01.014.
   PubMedGoogle Scholar
• Hegstad, S.; Hermansson, S.; Betner, I.; Spigset, O.; Falch, B. M. Screening and Quantitative Determination of Drugs of Abuse in Diluted Urine by UPLC-MS/MS. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2014, 947–948, 83–95. DOI: 10.1016/j.jchromb.2013.12.014.
   PubMedGoogle Scholar
• Kirk, L. M.; Brown, S. D. Beyond-Use Date Determination of Buprenorphine Buccal Solution Using a Stability-Indicating High-Performance Liquid Chromatographic Assay. J. Feline Med. Surg. 2015, 17, 1035–1040. DOI: 10.1177/1098612X15569329.
   PubMedGoogle Scholar
• Sisco, E.; Verkouteren, J.; Staymates, J.; Lawrence, J. Rapid Detection of Fentanyl, Fentanyl Analogues, and Opioids for on-Site or Laboratory Based Drug Seizure Screening Using Thermal Desorption DART-MS and Ion Mobility Spectrometry. Forensic Chem. 2017, 4, 108–115. DOI: 10.1016/j.forc.2017.04.001.
   PubMedGoogle Scholar
• Alizadeh, S.; Hasanzadeh, M.; Irandoost, A. Tramadol, Methadone and Buprenorphine-AuNPs Kit Based on Chemometrics Tools and Software. Sens Lett. 2020, 18, 227–235. DOI: 10.1166/sl.2020.4212.
   Google Scholar
• Mundhey, D.; Rajkondawar, V.; Daud, A.; Sapkal, N. A Study of Method Development, Validation and Forced Degradation for Quantification of Buprenorphine Hydrochloride in a Microemulsion Formulation. J. Appl. Pharm. Sci. 2016, 6, 159–169. DOI: 10.7324/JAPS.2016.601022.
   Google Scholar
• Concheiro, M.; Gray, T. R.; Shakleya, D. M.; Huestis, M. A. High-Throughput Simultaneous Analysis of Buprenorphine, Methadone, Cocaine, Opiates, Nicotine, and Metabolites in Oral Fluid by Liquid Chromatography Tandem Mass Spectrometry. Anal. Bioanal. Chem. 2010, 398, 915–924. DOI: 10.1007/s00216-010-3903-5.
   PubMed Web of Science ®Google Scholar
• Di Corcia, D.; Lisi, S.; Pirro, V.; Gerace, E.; Salomone, A.; Vincenti, M. Determination of Pharmaceutical and Illicit Drugs in Oral Fluid by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2013, 927, 133–141. DOI: 10.1016/j.jchromb.2013.01.025.
   PubMedGoogle Scholar
• Luthi, G.; Blangy, V.; Eap, C. B.; Ansermot, N. Buprenorphine and Norbuprenorphine Quantification in Human Plasma by Simple Protein Precipitation and Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2013, 77, 1–8. DOI: 10.1016/j.jpba.2012.12.023.
   PubMedGoogle Scholar
• Zhurkovich, I. K.; Rudenko, A. O.; Chelovechkova, V. V.; Merkusheva, I. A.; Lugovkina, N. V.; Kovrov, N. G.; Pchelintsev, M. V.; Verbitskaya, E. V.; Zvartau, É. É. Determination of Buprenorphine and Naloxone in Patient Blood Plasma Using HPLC-MS. Pharm. Chem. J. 2015, 48, 690–695. DOI: 10.1007/s11094-015-1161-8.
   Google Scholar
• Cohier, C.; Salle, S.; Fontova, A.; Megarbane, B.; Roussel, O. Determination of Buprenorphine, Naloxone and Phase I and Phase II Metabolites in Rat Whole Blood by LC-MS/MS. J. Pharm. Biomed. Anal. 2020, 180, 113042. DOI: 10.1016/j.jpba.2019.113042.
   PubMedGoogle Scholar
• Joshi, A.; Parris, B.; Liu, Y.; Heidbreder, C.; Gerk, P. M.; Halquist, M. Quantitative Determination of Buprenorphine, Naloxone and Their Metabolites in Rat Plasma Using Hydrophilic Interaction Liquid Chromatography Coupled with Tandem Mass Spectrometry. Biomed. Chromatogr. 2017, 31, e3785. DOI: 10.1002/bmc.3785.
   PubMedGoogle Scholar
• Bassan, D. M.; Erdmann, F.; Krull, R. Quantitative Determination of 43 Common Drugs and Drugs of Abuse in Human Serum by HPLC-MS/MS. Anal. Bioanal. Chem. 2011, 400, 43–50. DOI: 10.1007/s00216-011-4784-y.
   PubMed Web of Science ®Google Scholar
• Farmany, A.; Shamsara, M.; Mahdavi, H. Enhanced Electrochemical Biosensing of Buprenorphine Opioid Drug by Highly Stabilized Magnetic Nanocrystals. Sens. Actuators, B 2017, 239, 279–285. DOI: 10.1016/j.snb.2016.08.007.
   Google Scholar
• Asimakopoulos, A. G.; Kannan, P.; Higgins, S.; Kannan, K. Determination of 89 Drugs and Other Micropollutants in Unfiltered Wastewater and Freshwater by LC-MS/MS: An Alternative Sample Preparation Approach. Anal. Bioanal. Chem. 2017, 409, 6205–6225. DOI: 10.1007/s00216-017-0561-x.
   PubMed Web of Science ®Google Scholar
• Patel, V. N.; Jasani, M. H.; Chaudhary, A. B.; Pate, B. D. Stability Indicating Analytical Method Development and Validation for Estimation of Buprenorphine HCL and Naloxone HCL Dihydrate. World J. Pharm. Pharm. Sci. 2016, 5, 789–805. DOI: 10.20959/wjpps20166-6672.
   Google Scholar
• Di Corcia, D.; D'Urso, F.; Gerace, E.; Salomone, A.; Vincenti, M. Simultaneous Determination in Hair of Multiclass Drugs of Abuse (Including THC) by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2012, 899, 154–159. DOI: 10.1016/j.jchromb.2012.05.003.
   PubMed Web of Science ®Google Scholar
• Favretto, D.; Vogliardi, S.; Stocchero, G.; Nalesso, A.; Tucci, M.; Ferrara, S. D. High Performance Liquid Chromatography-High Resolution Mass Spectrometry and Micropulverized Extraction for the Quantification of Amphetamines, Cocaine, Opioids, Benzodiazepines, Antidepressants and Hallucinogens in 2.5 mg Hair Samples. J. Chromatogr. A 2011, 1218, 6583–6595. DOI: 10.1016/j.chroma.2011.07.050.
   PubMedGoogle Scholar
• Pichini, S.; Gottardi, M.; Marchei, E.; Svaizer, F.; Pellegrini, M.; Rotolo, M. C.; Algar, O. G.; Pacifici, R. Rapid Extraction, Identification and Quantification of Drugs of Abuse in Hair by Immunoassay and Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry. Clin. Chem. Lab. Med. 2014, 52, 679–686. DOI: 10.1515/cclm-2013-0784.
   PubMedGoogle Scholar
• Svaizer, F.; Lotti, A.; Gottardi, M.; Miozzo, M. P. Buprenorphine Detection in Hair Samples by Immunometric Screening Test: Preliminary Experience. Forensic Sci. Int. 2010, 196, 118–120. DOI: 10.1016/j.forsciint.2009.12.047.
   PubMedGoogle Scholar
• Mundhey, D. A.; Sapkal, N. P.; Daud, A. S. Simultaneous Quantification of Buprenorphine Hcl and Naloxone HCL by Vierordt’s Method. Pharm. Pharm. Sci. 2016, 8, 101–107.
   Google Scholar
• Pathy, K. Route Evaluation and Analytical HPLC Method Development of Buprenorphine, Naloxone, and Comparison Overall Efficiency of Naltrexone Nalbuphine Traces the Evolution of Various Approaches. Scholarly J. Food Nutr. 2018, 1, 17–33. DOI: 10.32474/sjfn.2018.01.000105.
   Google Scholar
• Norman, C.; McKirdy, B.; Walker, G.; Dugard, P.; NicDaeid, N.; McKenzie, C. Large-Scale Evaluation of Ion Mobility Spectrometry for the Rapid Detection of Synthetic Cannabinoid Receptor Agonists in Infused Papers in Prisons. Drug Test. Anal. 2021, 13, 644–663. DOI: 10.1002/dta.2945.
   PubMedGoogle Scholar